<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">SS</journal-id><journal-title-group><journal-title>Surgical Science</journal-title></journal-title-group><issn pub-type="epub">2157-9407</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ss.2014.510070</article-id><article-id pub-id-type="publisher-id">SS-50723</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  A Single Center Retrospective Analysis of Kraske’s Transsacral Approach: A Review
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>édric</surname><given-names>Bouts</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kurt</surname><given-names>Van der Speeten</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Surgical Oncology, Ziekenhuis Oost-Limburg, Genk, Belgium</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>cedric@bouts.be(ÉB)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>10</month><year>2014</year></pub-date><volume>05</volume><issue>10</issue><fpage>454</fpage><lpage>466</lpage><history><date date-type="received"><day>14</day>	<month>August</month>	<year>2014</year></date><date date-type="rev-recd"><day>10</day>	<month>September</month>	<year>2014</year>	</date><date date-type="accepted"><day>5</day>	<month>October</month>	<year>2014</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Aim: Presacral lesions are uncommon and represent a diagnostic and surgical challenge. The aim of this study is to present our experience with Kraske’s transsacral resection and to review current literature. Methods: Seven patients who had a transsacral resection between 2001 and 2013
   
  were reviewed retrospectively. Results: Two men and five women with a mean age of 39 (range 17
   
  - 60) years were diagnosed with a presacral lesion. The clinical presentation was nonspecific; pain was the most common symptom. All lesions were palpable on digital rectal examination. Magnetic resonance imaging (MRI) was necessary to assess the tumor’s extent, biological behavior and relationship to adjacent structures. MRI predicted malignancy with 100% accuracy. All lesions were located below S3 and underwent a transsacral resection. Pathological examination revealed four tailgut cysts, two epidermoid cysts and one chordoma. Postoperative complications included wound infections (two cases) and spasms of the gluteus muscle (one case). We reported no recurrence or mortality. Conclusion: Clinical awareness, the use of MRI in the routine work-up and avoidance of an incisional biopsy result in a good outcome after surgical resection of presacral lesions. Kraske’s approach can be used for presacral lesions below S3, resulting in low morbidity, no recurrence and no mortality.
 
</p></abstract><kwd-group><kwd>Presacral Tumor</kwd><kwd> Magnetic Resonance Imaging</kwd><kwd> Transsacral Approach</kwd><kwd> Kraske</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Presacral or retrorectal lesions are a rare and challenging surgical problem [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref3">3</xref>] . Major referral centers report an incidence of 1.4 to 6.3 adult patients per year [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] . They are usually asymptomatic lesions with a comprehensive differential diagnosis on magnetic resonance imaging (MRI). Excisional biopsy is required to obtain a pathological diagnosis [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref5">5</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref7">7</xref>] . The presacral space is a virtual space, confined by the rectum anteriorly, sacrum and coccyx posteriorly, ureter and iliac vessels laterally, peritoneal reflection superiorly and pelvic floor muscles inferiorly. As it is the site of fusion between the embryologic hindgut and neural ectoderm, various tumors may originate from these totipotential cells [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref8">8</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] .</p><p>A landmark paper in 1885 by Paul Kraske proposed a posterior approach to the rectal and retrorectal space. It exposes the mid rectum and presacral space after partial removal of the coccyx and the sacrum [<xref ref-type="bibr" rid="scirp.50723-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref12">12</xref>] . Since 1908, Miles’s abdominoperineal approach has replaced Kraske’s approach to control distal rectal cancer and its upward spread through lymphatics [<xref ref-type="bibr" rid="scirp.50723-ref13">13</xref>] . Kraske’s approach has remained an important technique to resect presacral lesions. It provides for a good access to an anatomically difficult region. As these lesions are mostly benign and asymptomatic, minimally invasive excision is necessary [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref14">14</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref18">18</xref>] . The aim of this manuscript is to present our experience with transsacral resection and to review current literature.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>This study represents a single center, retrospective analysis of presacral lesions. The operative notes between 2001 and 2013 were cross-checked with the database of pathology. Following data of seven patients were obtained: patient demographics, symptoms, clinical findings, technical investigations, perioperative details, pathological diagnosis and follow-up. No patients were excluded based on these findings. All lesions were resected through Kraske’s transsacral approach by the same surgeon (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Patients were placed in the prone jackknife position. After ellipsoidal incision over the sacrococcyx and splitting of the subcutis, the sacrum was approached and pelvic floor muscles were detached. A partial transection of the sacrum at the level of S4 or S5 was needed to approach the presacral space. The presacral lesion was dissected from surrounding structures. En bloc resection was performed when adjacent structures were involved. The defect was closed in layers and a drain was left in five cases. All patients received preoperative bowel preparation and postoperative antibiotics for five days. Diagnosis was confirmed on postoperative pathological examination. Follow-up depended on histological diagnosis and postoperative problems. All patients were seen at the outpatient clinic after four weeks. Benign cases were referred to a general practitioner. One malignant case (chordoma) was seen at the outpatient</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Kraske’s transsacral approach. (A) Partial sacrectomy at the level of S5. (D) Closure in layers. (B) En bloc resection of a tailgut cyst. (E) Tailgut cyst: macroscopic view. (C) Residual defect after resection of an epidermoid cyst. (F) Chordoma: macroscopic view</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-2300792x6.png"/></fig><p>clinic after one, two, four, eight, eleven, eighteen and twenty-six months. This patient underwent a postoperative MRI at four, eleven and twenty-five months.</p><p>An electronic search through text items and Medline Subject Headings (MESH) terms on PubMed was conducted using following key words: presacral space, sacrococcygeal region, presacral tumor, retrorectal tumor, tailgut cyst, epidermoid cyst, chordoma, MRI, surgical treatment, transsacral approach and Kraske. The same search was repeated on LIMO, a search platform for all collections of LIBIS net-libraries. References of the obtained articles were reviewed for additional relevant papers. Case reports, systematic reviews and meta-analysis were included.</p></sec><sec id="s3"><title>3. Results</title><p>Patient’s demographics and clinical findings were summarized in <xref ref-type="table" rid="table1">Table 1</xref>. No patients had undergone prior pelvic surgery. Concomitant relevant history included dilated seminal vesicles with ongoing perineal pain and irritable bowel syndrome with a recurrent anal fissure. Both problems resolved after surgical resection of the presacral lesion.</p><p>Preoperative work-up was done by MRI. Findings are summarized in <xref ref-type="table" rid="table2">Table 2</xref> and propose a broad differential diagnosis. Examples are shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>. Two diffusion-weighted MRI’s (DWI) were performed, using apparent diffusion coefficient (ADC) values at low (0 s/mm<sup>2</sup>) and high (1000 s/mm<sup>2</sup>) diffusion gradients. ADC values were high for both diffusion gradients (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Five patients underwent computed tomography (CT) before MRI. Other technical investigations before MRI or CT included a positron emission tomography (PET), a transrectal ultrasonography (TRUS), a transabdominal ultrasonography and two anoscopies. No presacral lesions were found. TRUS illustrated dilated seminal vesicles. Transabdominal ultrasonography suggested acute appendicitis. One anoscopy revealed an anal fissure.</p><p>Preoperative biopsy was not indicated. Excisional resection was macroscopically complete in all cases. Rectal involvement required partial excision and closure of the rectal wall in six cases. Partial sacrectomy was performed at the level of S4 (three cases) or S5 (four cases). One defect required closure by a gluteus flap transfer and re-approximation of the external rectal sphincter. The operative time ranged from 103 to 196 minutes, with an average of 152 minutes. No intraoperative complications were noted and blood loss was negligible.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Patients with a presacral lesion: demographics and clinical findings (n = 7)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Demographics and clinical findings</th><th align="center" valign="middle" >Number (n)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Age (years)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mean</td><td align="center" valign="middle" >39 y</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Range</td><td align="center" valign="middle" >17 y - 60 y</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >71.4%</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >28.6%</td></tr><tr><td align="center" valign="middle" >Symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Asymptomatic</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Symptomatic</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >85.7%</td></tr><tr><td align="center" valign="middle" >Perineal pain</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >28.6%</td></tr><tr><td align="center" valign="middle" >Abdominal pain</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >28.6%</td></tr><tr><td align="center" valign="middle" >Change in bowel habit</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >28.6%</td></tr><tr><td align="center" valign="middle" >Tenesmus</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Dyspareunia</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Sacral swelling</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Digital rectal examination</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Palpable mass or bulge</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >100%</td></tr><tr><td align="center" valign="middle" >Painful</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >42.9%</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Presacral lesions: magnetic resonance findings (n = 7)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >MRI findings</th><th align="center" valign="middle" >Number (n)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Tumor location</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Above S3</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0%</td></tr><tr><td align="center" valign="middle" >Below S3</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >100%</td></tr><tr><td align="center" valign="middle" >Tumor Size (cm)</td><td align="center" valign="middle" >Range: 5.9 cm; Mean: 2.8 - 10.5 cm</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Involvement of surrounding structures</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >57.1%</td></tr><tr><td align="center" valign="middle" >Tumor morphology</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Cystic</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >85.7%</td></tr><tr><td align="center" valign="middle" >Solid</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Signal intensity</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Homogeneity</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >100%</td></tr><tr><td align="center" valign="middle" >Heterogeneity</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0%</td></tr><tr><td align="center" valign="middle" >Tumor margin</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Sharp</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >100%</td></tr><tr><td align="center" valign="middle" >Irregular/Infiltrative</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0%</td></tr><tr><td align="center" valign="middle" >Gadolinium enhancement</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >42.9%</td></tr><tr><td align="center" valign="middle" >Septation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Unilocular</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >42.9%</td></tr><tr><td align="center" valign="middle" >Polylocular</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >57.1%</td></tr><tr><td align="center" valign="middle" >Preferable diagnosis</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Tailgut cyst</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >71.4%</td></tr><tr><td align="center" valign="middle" >Chordoma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Endometriosis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr></tbody></table></table-wrap><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Magnetic resonance imaging of presacral lesions. (A) Sagittal T2-weighted MRI of a tailgut cyst: located below S3, sharp tumor margins, high signal intensity, homogeneous, unilocular. (B) Coronal T2-weighted MRI of a tailgut cyst: external compression of the rectum. (C) Sagittal T2-weighted MRI of a chordoma: located below S3, extension behind the sacrum, sharp tumor margins, high signal intensity, homogeneous, multiple septations. (D) Sagittal T2-weighted MRI of an epidermoid cyst: located below S3, sharp tumor margins, high signal intensity, homogeneous. (E) Axial T1-weighted MRI of an epidermoid cyst: Gadolinium enhancement in the wall of the lesion</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-2300792x7.png"/></fig><fig-group id="fig3"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Diffusion-weighted MRI of an epidermoid cyst. (A) ADC map: low signal intensity. (B) DWI with low diffusion gradient (b = 0 s/mm<sup>2</sup>): high ADC value. (C) DWI with high diffusion gradient (b = 1000 s/mm<sup>2</sup>): high ADC value.</title></caption><fig id ="fig3_1"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-2300792x8.png"/></fig><fig id ="fig3_2"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-2300792x9.png"/></fig><fig id ="fig3_3"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-2300792x10.png"/></fig></fig-group><p>The mean postoperative hospital stay was 5, 3 days, ranging from 4 to 8 days. We noted no problems, apart from perineal discomfort. All patients left the hospital in good condition. During the first month (short-term morbidity), pain and discomfort diminished. Two cases of wound infection were noted, respectively after five and thirteen days. In the initial case, a recurrent wound infection was seen after eleven days. Both cases healed after conservative wound treatment. We encountered one long-lasting complication: exercise-induced involuntary contractions of the left gluteus muscle after flap transfer. These painful episodes lasted about ten seconds. They improved progressively with physical therapy. After eighteen months, there were no problems, except when doing heavy lifting from the squat position. Final consultation after twenty-four months revealed further favorable development.</p><p>Histological diagnosis included four tailgut cysts, two epidermoid cysts and one chordoma. An overview is summarized in <xref ref-type="table" rid="table3">Table 3</xref>. Maximal diameter ranged from 2.8 cm to 10 cm. Mean diameter was 5.3 cm. Excision was microscopically complete in all cases. Tailgut cysts were characterized by their multicystic aspect, thin wall, mucoid material, various epithelial types and a surrounding disorganized muscle layer (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Epidermoid cysts were lined with malpighian epithelium, containing laminated keratin contents. An inflammatory response, based on rupture, was present in one cyst (<xref ref-type="fig" rid="fig5">Figure 5</xref>). No atypia, sacral bone defects or calcifications were noted. The chordoma consisted of multiple lobules and physaliphorous cells with intracytoplasmic vacuoles (<xref ref-type="fig" rid="fig6">Figure 6</xref>). There were no regions of chondroid differentiation or chondrosarcoma. The cells labeled with cytokeratin and S-100 protein. The proliferation marker Ki67 was positive in less than 2% of all cells. Sacral destruction was noted.</p></sec><sec id="s4"><title>4. Discussion</title><p>Presacral lesions represent a diagnostic and surgical challenge. Presentation is asymptomatic or nonspecific. They originate from a complex anatomical region with a broad differential diagnosis and a difficult approach. [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref6">6</xref>] Literature only contains small series. Jao reports the largest study, being one with 120 patients [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] . This single center retrospective analysis is in line with current literature.</p><sec id="s4_1"><title>4.1. Overview of Presacral Lesions</title><p>Presacral lesions usually occur between the age of 40 and 60. They are classified by their predominant cell line</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Presacral lesions: histological evaluation (n = 7)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Histological evaluation</th><th align="center" valign="middle" >Number (n)</th><th align="center" valign="middle" >(Male:Female)</th><th align="center" valign="middle" >Percentage (%)</th><th align="center" valign="middle" >(Male:Female)</th></tr></thead><tr><td align="center" valign="middle" >Benign</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Tailgut cyst</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >(1:3)</td><td align="center" valign="middle" >57.1%</td><td align="center" valign="middle" >(25%:75%)</td></tr><tr><td align="center" valign="middle" >Epidermoid cyst</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >(0:2)</td><td align="center" valign="middle" >28.6%</td><td align="center" valign="middle" >(0%:100%)</td></tr><tr><td align="center" valign="middle" >Malignant</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Chordoma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >(1:0)</td><td align="center" valign="middle" >14.3%</td><td align="center" valign="middle" >(100%:0%)</td></tr></tbody></table></table-wrap><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> Photomicrographs of a tailgut cyst. (A) HE stain illustrates the multilocular aspect, various epithelial types and a disorganized muscle layer. (B) Cytokeratin 5/6 stain illustrates the epithelial tissues. (C) Desmin stain illustrates the disorganized, interrupted muscle layer</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-2300792x11.png"/></fig><fig id="fig5"  position="float"><label><xref ref-type="fig" rid="fig5">Figure 5</xref></label><caption><title> Photomicrograph of an epidermoid cyst. HE stain illustrates a malpighian epithelium with a granular layer. Inflammatory response due to rupture of the cyst</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-2300792x12.png"/></fig><fig id="fig6"  position="float"><label><xref ref-type="fig" rid="fig6">Figure 6</xref></label><caption><title> Photomicrographs of a chordoma. (A) HE stain illustrates the typical physaliphorous cells, containing numerous, variably sized, intracytoplasmic vacuoles. (B) Keratin stain. (C) S-100 protein stain</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-2300792x13.png"/></fig><p>type. Five categories are obtained: congenital, inflammatory, neurogenic, osseous and miscellaneous (<xref ref-type="table" rid="table4">Table 4</xref>) [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref19">19</xref>] . Lev-Chelouche et al. suggest another classification based on tumor origin and nature, but this has no influence on the management of an individual patient [<xref ref-type="bibr" rid="scirp.50723-ref14">14</xref>] .</p><p>All lesions in this study were congenital. This category accounts for 55% to 70% of all presacral lesions. Developmental cysts include epidermoid cysts, dermoid cysts, tailgut cysts or teratomas, accounting for 60% of all congenital lesions [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref20">20</xref>] . They have a male:female ratio ranging from 1:2 to 1:5, partly explained by findings during routine gynecologic investigations [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref7">7</xref>] . This concurs with our findings: female predominance (83.3%) was noted in developmental cysts and one patient was referred by a gynecologist. The most common malignant presacral lesion is a chordoma. It has a male:female ratio of 2:1. Chordomas are usually slow growing lesions, rarely occur before the age of 30 and frequently cause pain and nerve impingement [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] . We encountered one chordoma in a 40-year-old male. He was asymptomatic, apart from sacral swelling due to tumor extension behind the sacrum. Inflammatory lesions represent abscesses, fistulas and granulomas. Some series do not include those lesions [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] . Neurogenic lesions arise from peripheral nerves, representing 10% of all presacral lesions. Ependymomas have the highest incidence in this category. Osseous lesions represent 5% to 10% of all presacral masses. Miscellaneous lesions are very diverse, accounting for the remaining 10% to 25%. Metastatic disease, usually from the rectum, constitutes an important part [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] .</p></sec><sec id="s4_2"><title>4.2. Clinical Presentation</title><p>The asymptomatic or nonspecific presentation delays the correct diagnosis of presacral lesions. Series report 14% to 56% of cases without symptoms [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref14">14</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref20">20</xref>] . We reported 85.7% of patients having at least one symptom on detailed questioning. Misdiagnoses include fistula in ano, perianal abscesses, proctalgia fugax, pilonidal disease, psychogenic pain, back pain and postpartum pain [<xref ref-type="bibr" rid="scirp.50723-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref21">21</xref>] . Singer et al. report seven cases which had undergone an average of 4.7 invasive procedures before being correctly diagnosed with a presacral lesion [<xref ref-type="bibr" rid="scirp.50723-ref7">7</xref>] . Other results conclude that 36.2% of the cases had undergone a previous procedure [<xref ref-type="bibr" rid="scirp.50723-ref16">16</xref>] . If symptomatic, duration between symptoms and diagnosis is an average of twelve months [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] . Possible symptoms are caused by compression, invasion, infection, necrosis or malignancy [<xref ref-type="bibr" rid="scirp.50723-ref8">8</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref14">14</xref>] . Pain complaints of the perineum, back and abdomen are the most common symptoms [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref22">22</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref24">24</xref>] . Glasgow et al. conclude that male gender, an age over 60 years and pain is suggestive of malignancy. Pain complaints occur</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Classification of presacral masses</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Classification</th><th align="center" valign="middle" >Benign</th><th align="center" valign="middle" >Malignant</th></tr></thead><tr><td align="center" valign="middle" >Congenital</td><td align="center" valign="middle" >Developmental cyst Dermoid cyst Epidermoid cyst Tailgut cyst Teratoma Anterior meningocele Rectal duplication Adrenal rest tumor</td><td align="center" valign="middle" >Chordoma Teratocarcinoma</td></tr><tr><td align="center" valign="middle" >Inflammatory</td><td align="center" valign="middle" >Granuloma Abscess perineal abscess pelvirectal abscess Fistula</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Neurogenic</td><td align="center" valign="middle" >Neurofibroma Neurilemmoma Ganglioneuroma Ependymoma</td><td align="center" valign="middle" >Neuro(fibro)sarcoma</td></tr><tr><td align="center" valign="middle" >Osseous</td><td align="center" valign="middle" >Osteoma Sacral bone cyst Giant cell tumor</td><td align="center" valign="middle" >Osteosarcoma Chondrosarcoma Ewing’s sarcoma Giant cell sarcoma</td></tr><tr><td align="center" valign="middle" >Miscellaneous</td><td align="center" valign="middle" >Desmoid tumor Fibroma Leiomyoma Lipoma Hemangioma Endothelioma Pericytoma Lymphangioma Myelolipoma Desmoid tumor</td><td align="center" valign="middle" >Metastatic disease Fibrosarcoma Leiomyosarcoma Liposarcoma Hemangioendothelial sarcoma Carcinoid</td></tr></tbody></table></table-wrap><p>in 86% to 88% of malignant lesions, in contrast to 22% to 39% of benign lesions [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] . Our findings do not concur with this conclusion: pain or dyspareunia was reported in five benign lesions (83.3%), while none were noted in the chordoma. Other common symptoms include constipation, overflow diarrhea and tenesmus, which we reported in three cases [<xref ref-type="bibr" rid="scirp.50723-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref24">24</xref>] . Many other, but less common symptoms are described. None were seen in this study. Sexual dysfunction, pain of lower limbs and dysfunction of lower limbs are caused by invasion of the sacral plexus. A recurrent fistula, an abscess or a secreting sinus could be a sign of an infected presacral mass [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref17">17</xref>] . Life-threatening dystocia, due to obstruction by a presacral mass, has been described in several case reports [<xref ref-type="bibr" rid="scirp.50723-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref26">26</xref>] . A meningocele can cause postural headache and acute meningitis [<xref ref-type="bibr" rid="scirp.50723-ref27">27</xref>] . Anorectal stenosis is suggestive of a Currarino triad, consisting of an anorectal malformation, a sacral bony defect and a presacral mass [<xref ref-type="bibr" rid="scirp.50723-ref28">28</xref>] .</p><p>The sensitivity of digital rectal examination is inconsistent. Several series report 75% to 100% of the presacral lesions to be palpable [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref23">23</xref>] . Glasgow et al. and Bosca et al. report respectively only 35% and 47.6% to be palpable [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] . Differences are attributed to the location and the extent of selected tumors. Lesions below S3 can be palpated on rectal examination [<xref ref-type="bibr" rid="scirp.50723-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref21">21</xref>] . This concurs with our findings. If the lesion is present on rectal examination, estimation of tumor size, location, mobility, consistency and lobulation is possible [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref30">30</xref>] .</p><p>We conclude that clinical awareness is important to detect presacral lesions, because they are usually slow growing and latent in onset. Knowledge of possible symptoms is necessary. A digital rectal examination is recommended, as it can detect lesions below S3. Further investigations are always indicated.</p></sec><sec id="s4_3"><title>4.3. Diagnosis</title><p>Diagnosis of presacral lesions is based on imaging and histology: MRI has become the cornerstone in the preoperative work-up and pathological examination confirms the classification [<xref ref-type="bibr" rid="scirp.50723-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref18">18</xref>] .</p><p>Due to the excellent soft-tissue resolution and multiplanar capacity, MRI is the best imaging modality to assess tumor location, size, morphology and adjacent structures [<xref ref-type="bibr" rid="scirp.50723-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] . The risk of malignancy can be estimated based on following features: heterogeneity, solid appearance, irregular or infiltrative borders, variable enhancement after gadolinium administration, rapid growth and extension above S3 [<xref ref-type="bibr" rid="scirp.50723-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref18">18</xref>] . Our findings predicted malignancy with 100% accuracy, confirming the current literature. Biological behavior also correlates with diffusion restriction. DWI can distinguish benign and malignant lesions, using quantitative ADC measurements. Several authors report significantly higher ADC values at high diffusion gradients for benign lesions [<xref ref-type="bibr" rid="scirp.50723-ref31">31</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref33">33</xref>] . Our findings concur with this conclusion. Specific diagnosis by MRI is difficult. Glasgow et al. report 28% of MRI diagnoses to be in accordance with the histological diagnosis [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] . Radiological evaluation provided a differential diagnosis in order of preference. Accuracy was 57.1%: two epidermoid cysts were mistaken for tailgut cysts and one tailgut cyst was mistaken for endometriosis. Presacral cysts usually have low signal intensity on T1-weighted images and high signal intensity on T2-weighted images. This may be influenced by the cyst’s content: blood, proteins and mucins cause higher signal intensity on T1-weighted images. Fat content is best seen on T1-weighted images using fat suppression. This is suggestive of a dermoid cyst. Tailgut cysts are multicystic, in contrast to other cystic masses. A chordoma is lobulated with a heterogeneous high signal intensity on T2-weighted images and low-intermediate signal intensity on T1-weighted images. Gadolinium injection reveals a heterogeneous enhancement with a honeycomb appearance [<xref ref-type="bibr" rid="scirp.50723-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref34">34</xref>] .</p><p>CT allows us to detect presacral lesions, differentiate cystic from solid lesions and evaluate tumor extent [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref9">9</xref>] . The soft-tissue resolution remains inferior to MRI. Glasgow et al. report 18% of radiological diagnosis to be in accordance with histology [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] . Multi-slice CT illustrates an evolution in reconstructing and evaluating section planes [<xref ref-type="bibr" rid="scirp.50723-ref35">35</xref>] . CT findings always indicated the need for additional MRI to precisely define tumor characteristics.</p><p>Other technical investigations are of lesser value. Plain X-rays can reveal a mass, sacral destruction or calcifications. Calcifications are suggestive of a teratoma [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref21">21</xref>] . A scimitar sign is typical for an anterior meningocele [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref27">27</xref>] . X-rays are neither sensitive, nor specific and downplay possible damage [<xref ref-type="bibr" rid="scirp.50723-ref34">34</xref>] . Developmental cysts can be misdiagnosed as a chronic draining sinus. Fistulography can identity a presacral lesion as their origin [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] . Endoscopy can reveal an extra-luminal compression in large lesions. An edematous rectum wall is suggestive of an infected cyst [<xref ref-type="bibr" rid="scirp.50723-ref21">21</xref>] . Sensitivity of endoscopy has been documented at 53 percent [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] . TRUS is an inexpensive method to roughly estimate the extent of presacral lesions and their relation to the adjacent structures [<xref ref-type="bibr" rid="scirp.50723-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref36">36</xref>] . One patient underwent TRUS to evaluate his prostate, but no presacral lesion was documented.</p><p>The role of biopsy is limited. Complications include fistula formation, abscess formation, tumor seeding, recurrence or meningitis [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref30">30</xref>] . Transrectal biopsy is never recommended. CT-guided extrarectal or presacral biopsy is considered in inoperable cases if it changes the non-operative treatment (for example metastatic disease and lymphomas) [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref37">37</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref38">38</xref>] .</p><p>Histological conformation is made postoperative and determines further follow-up. Epidermoid cysts are unilocular lesions, which are lined with stratified squamous epithelium and filled with clear fluid. They do not contain skin appendages, in contrast to dermoid cysts [<xref ref-type="bibr" rid="scirp.50723-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref34">34</xref>] . Tailgut cysts are multicystic lesions, filled with mucoid contents and lined with ciliated columnar cells, squamous cells and transitional cells [<xref ref-type="bibr" rid="scirp.50723-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref34">34</xref>] . Rectal duplication cysts are differentiated based on following criteria: an organized smooth-muscle coat (desmine staining), continuity with the rectum and a mucosal lining similar to the rectal mucosa [<xref ref-type="bibr" rid="scirp.50723-ref34">34</xref>] . Teratomas are diagnosed based on their three germ layers [<xref ref-type="bibr" rid="scirp.50723-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref34">34</xref>] . The microscopic hallmark of chordomas are the physaliphorous cells, which contain glycogen or mucin. Conventional chordomas are characterized by the absence of mesenchymal components, in contrast to chondroidchordomas and chondrosarcomas. S-100 protein expression is typically present in both chordomas and chondrosacromas, while the latter does not express cytokeratin [<xref ref-type="bibr" rid="scirp.50723-ref39">39</xref>] .</p><p>We conclude that MRI is the best way to evaluate the extent and characteristics of a presacral lesion. The aim is to choose the appropriate surgical approach and estimate the extent of the operation. Specific histological diagnosis is determined postoperative.</p></sec><sec id="s4_4"><title>4.4. Treatment</title><p>Surgical resection is required. Presacral lesions can grow and cause obstruction or invasion. Benign lesions risk causing bleeding, dystocia, infection (for example cysts or meningoceles) or malignant transformation (for example teratomas). Malignant lesions must be excised to prevent metastasis and improve life expectancy [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref21">21</xref>] .</p><p>Resection is possible through an anterior (abdominal), posterior or combined (abdominosacral) approach. This is determined by two steps:</p><p>1) Tumor extent: above or below S3.</p><p>2) Involvement of the sacrum, the pelvic sidewall and the viscera.</p><p>Woodfield et al. propose an algorithm for the surgical management of presacral tumors. A posterior approach is used for tumors below S3. Sacrectomy is necessary in case of difficult access, large tumors or sacral involvement. Tumors above S3 or tumors with involvement of the pelvic sidewall or the viscera require an anterior approach. A combined approach is recommended in the following cases: tumor extension above and below S3, sacral invasion in lesions above S3 and involvement of the sacrum with the pelvic sidewall or the viscera in lesions below S3 [<xref ref-type="bibr" rid="scirp.50723-ref3">3</xref>] . Other series report similar conclusions, but the proximal border differs between S2, S3 and S4 [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref30">30</xref>] .</p><p>Several posterior approaches are described: perineal, transsacral, transanal, intersphincteric, transsphincteric and transvaginal. <xref ref-type="table" rid="table5">Table 5</xref> provides an overview of their uses and limitations [<xref ref-type="bibr" rid="scirp.50723-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref40">40</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref42">42</xref>] .</p><p>The transsacral approach represents a minimally invasive way to provide an excellent view of low-lying presacral tumors and sacral nerve roots. Kraske’s approach lost support because of high rates of morbidity (70%) and recurrence (90%) of distal rectal cancer [<xref ref-type="bibr" rid="scirp.50723-ref43">43</xref>] . Local posterior excision of early rectal cancer still has a place in selected patients, but a transanal approach is preferred [<xref ref-type="bibr" rid="scirp.50723-ref44">44</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref45">45</xref>] . Kraske’s approach is successfully used for presacral lesions resulting in low morbidity, recurrence and mortality [<xref ref-type="bibr" rid="scirp.50723-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref40">40</xref>] . Complications include</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Different posterior approaches: uses and limitations</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Posterior approaches</th><th align="center" valign="middle" >Uses and advantages</th><th align="center" valign="middle" >Limitations and disadvantages</th></tr></thead><tr><td align="center" valign="middle" >Perineal</td><td align="center" valign="middle" >Good exposition of distal presacral space For lesions deeper and higher compared to an intersphincteric approach Preservation of coccyx with less postoperative pain Preservation of sphincter function</td><td align="center" valign="middle" >Only for low-lying lesions Limited visualization of possible cranial extension</td></tr><tr><td align="center" valign="middle" >Transsacral</td><td align="center" valign="middle" >Best exposition of the presacral space For lesions higher compared a perineal approach Less recurrence compared to a perineal approach Preservation of sphincter function Resection of mid-rectal lesions in carefully selected patients</td><td align="center" valign="middle" >No visualization of pelvic vessels: risk of bleeding Risk of posterior discomfort Risk of wound dehiscence Risk of fistula formation Risk of sacral nerve injury</td></tr><tr><td align="center" valign="middle" >Transsphincteric</td><td align="center" valign="middle" >Good exposition of the mid rectal lumen Useful in case of extension into the rectal wall Avoidance of sacral nerve injury</td><td align="center" valign="middle" >Only for low-lying lesions Risk of sphincter dysfunction Risk of fecal fistula formation</td></tr><tr><td align="center" valign="middle" >Intersphincteric</td><td align="center" valign="middle" >Avoidance of sacral nerve injury Preservation of sphincter function</td><td align="center" valign="middle" >Only for very low-lying lesions Contra-indication in case of preoperative suspicion of malignancy</td></tr><tr><td align="center" valign="middle" >Transanal/rectal</td><td align="center" valign="middle" >Useful in case of transrectal ruptured cysts Useful for rectal polyps First choice in local treatment of early rectal cancer for carefully selected patients</td><td align="center" valign="middle" >Limited visualization of presacral space Risk of incomplete resection (cystic lesions) Risk of bleeding Risk of fecal incontinence Special material Technical experience</td></tr><tr><td align="center" valign="middle" >Transvaginal</td><td align="center" valign="middle" >Useful in cases that deviate from the midline</td><td align="center" valign="middle" >Only for prerectal lesions Risk of rectovaginal fistula formation Risk of dyspareunia</td></tr></tbody></table></table-wrap><p>intraoperative bleeding, fistula development, wound infection, rectal injury, incontinency, impotency and recurrence [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref40">40</xref>] . Blood loss is minimal with little need for transfusion [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref16">16</xref>] . There was no transfusion required in our series. Intraoperative bleeding can be dangerous, as this approach does not allow for good visualization of the vasculature [<xref ref-type="bibr" rid="scirp.50723-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref23">23</xref>] . Pelvic packing may be necessary to stop the hemorrhage [<xref ref-type="bibr" rid="scirp.50723-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref18">18</xref>] . Partial sacrectomy and intraoperative cystic drainage allow for better oversight, although cystic drainage increases the risk of seeding [<xref ref-type="bibr" rid="scirp.50723-ref15">15</xref>] . An extraperitoneal iliac incision for vascular isolation can be useful in large tumors [<xref ref-type="bibr" rid="scirp.50723-ref6">6</xref>] . Fistula formation is a common complication [<xref ref-type="bibr" rid="scirp.50723-ref40">40</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref43">43</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref46">46</xref>] . Recent series report less fistula formation (0% - 20%) if Kraske’s approach is strictly used for presacral instead of rectal lesions [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref16">16</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref24">24</xref>] . Rectal damage increases the risk of postoperative fistulas. We reported no fistulas, although partial excision of the rectal wall was needed in six cases. Inserting a finger in the rectum helped to differentiate rectal fibers from surrounding tissues and also prevented rectal injury. Preoperative bowel preparation is indispensable. Recent studies report an incidence of wound infections between 4.3% and 30% [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref14">14</xref>] -[<xref ref-type="bibr" rid="scirp.50723-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref24">24</xref>] . This is consistent with our findings (28.5%). Postoperative antibiotic prophylaxis remains important. One infection occurred after resecting a large mass (&gt;10 cm). Flap transfer can provide a solution by preventing traction and improve healing in large defects. It is also useful in preventing wound dehiscence after partial sacrectomy [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] . We encountered involuntary contractions of the gluteus muscle after a gluteus flap transfer. There were two possible explanations: resection of the sacrum caused partial removal of the anchoring of the gluteus musculature or placement of a transgluteal drain damaged a motoric nerve. The contractions improved with physiotherapy. In our series, resections were limited to the level of S4. Incontinence and impotency are complications due to nerve damage: a unilateral S3 root must be preserved [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] .</p><p>Prognosis depends on the pathology and surgical margins [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] . Benign lesions are more likely to be resected completely compared to malignant lesions [<xref ref-type="bibr" rid="scirp.50723-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref15">15</xref>] . Little manipulation and no laceration of the tumor are important factors in preventing recurrence [<xref ref-type="bibr" rid="scirp.50723-ref14">14</xref>] . Partial sacrectomy is associated with less recurrence compared to a perineal approach, especially for cystic lesions and teratomas [<xref ref-type="bibr" rid="scirp.50723-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref20">20</xref>] . En bloc resection is important when surrounding structures are involved [<xref ref-type="bibr" rid="scirp.50723-ref3">3</xref>] . Lev-Chelouche et al. report different recurrence and survival rates for benign, malignant, congenital and acquired lesions [<xref ref-type="bibr" rid="scirp.50723-ref14">14</xref>] . We report no significant morbidity, recurrence or mortality, bearing in mind the large proportion of benign lesions (85.7%). Benign lesions have a survival rate of approximately 100% with a low recurrence rate [<xref ref-type="bibr" rid="scirp.50723-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.50723-ref17">17</xref>] . Jao et al. report 15.2% recurrence of benign lesions [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] . Malignant lesions have a worse prognosis. Jao et al. report an overall five-year survival rate of 17%, although chordomas have a better prognosis (five-year survival rate of 75%) [<xref ref-type="bibr" rid="scirp.50723-ref1">1</xref>] . Glasgow et al. report a 100% recurrence rate with a median disease-free time span of 24 months [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] . Woodfield et al. report recurrence in two of seven malignant lesions, both chordomas [<xref ref-type="bibr" rid="scirp.50723-ref3">3</xref>] . Reports of a longer recurrence-free interval after aggressive postoperative radiation therapy remain anecdotal [<xref ref-type="bibr" rid="scirp.50723-ref2">2</xref>] . We report no recurrence or mortality ten years after radical resection of a chordoma.</p></sec></sec><sec id="s5"><title>5. Conclusion</title><p>Presacral lesions are rare. Diagnosis is difficult given the various presentations. MRI provides an excellent way to evaluate presacral lesions, assess the risk of malignancy and determine the surgical approach. Kraske’s transsacral approach is the first choice for presacral lesions below S3, if the pelvic sidewall or viscera are not involved. It results in a good outcome, low morbidity, no recurrence and no mortality. Kraske’s approach belongs to a surgeon’s armamentarium.</p></sec><sec id="s6"><title>Acknowledgements</title><p>The authors thank Dr. Geert Verswijvel and Dr. Johan Van Robays for their expertise concerning the radiological and histological images.</p></sec><sec id="s7"><title>Disclosure Statement</title><p>Theauthors declare that they have no competing interests.</p></sec><sec id="s8"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.50723-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Jao, S.W., Beart Jr., R.W., Spencer, R.J., Reiman, H.M. and Ilstrup, D.M. (1985) Retrorectal Tumors. Mayo Clinic Experience, 1960-1979. Diseases of the Colon &amp; Rectum, 28, 644-652. http://dx.doi.org/10.1007/BF02553440</mixed-citation></ref><ref id="scirp.50723-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Glasgow, S.C., Birnbaum, E.H., Lowney, J.K., Fleshman, J.W., Kodner, I.J., Mutch, D.G., et al. (2005) Retrorectal Tumors: A Diagnostic and Therapeutic Challenge. Diseases of the Colon &amp; Rectum, 48, 1581-1587.  
http://dx.doi.org/10.1007/s10350-005-0048-2</mixed-citation></ref><ref id="scirp.50723-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Woodfield, J.C., Chalmers, A.G., Phillips, N. and Sagar, P.M. (2008) Algorithms for the Surgical Management of Retrorectal Tumours. British Journal of Surgery, 95, 214-221. http://dx.doi.org/10.1002/bjs.5931</mixed-citation></ref><ref id="scirp.50723-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Hobson, K.G., Ghaemmaghami, V., Roe, J.P., Goodnight, J.E. and Khatri, V.P. (2005) Tumors of the Retrorectal Space. Diseases of the Colon &amp; Rectum, 48, 1964-1974. http://dx.doi.org/10.1007/s10350-005-0122-9</mixed-citation></ref><ref id="scirp.50723-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Yang, B.L., Gu, Y.F., Shao, W.J., Chen, H.J., Sun, G.D., Jin, H.Y., et al. (2010) Retrorectal Tumors in Adults: Magnetic Resonance Imaging Findings. World Journal of Gastroenterology, 16, 5822-5829.  
http://dx.doi.org/10.3748/wjg.v16.i46.5822</mixed-citation></ref><ref id="scirp.50723-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Wolpert, A., Beer-Gabel, M., Lifschitz, O. and Zbar, A.P. (2002) The Management of Presacral Masses in the Adult. Techniques in Coloproctology, 6, 43-49. http://dx.doi.org/10.1007/s101510200008</mixed-citation></ref><ref id="scirp.50723-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Singer, M.A., Cintron, J.R., Martz, J.E., Schoetz, D.J. and Abcarian, H. (2003) Retrorectal Cyst: A Rare Tumor Frequently Misdiagnosed. Journal of the American College of Surgeons, 196, 880-886.  
http://dx.doi.org/10.1016/S1072-7515(03)00133-9</mixed-citation></ref><ref id="scirp.50723-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Bullard Dunn, K. (2010) Retrorectal Tumors. Surgical Clinics of North America, 90, 163-171, Table of Contents.  
http://dx.doi.org/10.1016/j.suc.2009.09.009</mixed-citation></ref><ref id="scirp.50723-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ghosh, J., Eglinton, T., Frizelle, F.A. and Watson, A.J. (2007) Presacral Tumours in Adults. Surgeon, 5, 31-38.  
http://dx.doi.org/10.1016/S1479-666X(07)80109-0</mixed-citation></ref><ref id="scirp.50723-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Hassan, I. and Wietfeldt, E.D. (2009) Presacral Tumors: Diagnosis and Management. Clinics in Colon and Rectal Surgery, 22, 84-93. http://dx.doi.org/10.1055/s-0029-1223839</mixed-citation></ref><ref id="scirp.50723-ref11"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kraske</surname><given-names> P. </given-names></name>,<etal>et al</etal>. (<year>1885</year>)<article-title>Zur Exstirpation Hochsitzender Mast Darm Krebse</article-title><source> Verhandlungen der Deutschen Gesellschaft für Chirurgie</source><volume> 14</volume>,<fpage> 464</fpage>-<lpage>474</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.50723-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Kraske, P., Perry, E.G. and Hinrichs, B. (1989) A New Translation of Professor Dr P. Kraske’s Zur Exstirpation Hochsitzender Mastdarmkrebse. 1885. Australian and New Zealand Journal of Surgery, 59, 421-424.</mixed-citation></ref><ref id="scirp.50723-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Campos, F.G., Habr-Gama, A., Nahas, S.C. and Perez, R.O. (2012) Abdominoperineal Excision: Evolution of a Centenary Operation. Diseases of the Colon Rectum, 55, 844-853. http://dx.doi.org/10.1097/DCR.0b013e31825ab0f7</mixed-citation></ref><ref id="scirp.50723-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Lev-Chelouche, D., Gutman, M., Goldman, G., Even-Sapir, E., Meller, I., Issakov, J., et al. (2003) Presacral Tumors: A Practical Classification and Treatment of a Unique and Heterogeneous Group of Diseases. Surgery, 133, 473-478. 
http://dx.doi.org/10.1067/msy.2003.118</mixed-citation></ref><ref id="scirp.50723-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Lin, C., Jin, K., Lan, H., Teng, L., Lin, J. and Chen, W. (2011) Surgical Management of Retrorectal Tumors: A Retrospective Study of a 9-Year Experience in a Single Institution. Journal of OncoTargets and Therapy, 4, 203-208.</mixed-citation></ref><ref id="scirp.50723-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Chereau, N., Lefevre, J.H., Meurette, G., Mourra, N., Shields, C., Parc, Y., et al. (2013) Surgical Resection of Retrorectal Tumours in Adults: Long-Term Results in 47 Patients. Colorectal Disease, 15, e476-e482. 
http://dx.doi.org/10.1111/codi.12255</mixed-citation></ref><ref id="scirp.50723-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Buchs, N., Taylor, S. and Roche, B. (2007) The Posterior Approach for Low Retrorectal Tumors in Adults. International Journal of Colorectal Disease, 22, 381-385. http://dx.doi.org/10.1007/s00384-006-0183-9</mixed-citation></ref><ref id="scirp.50723-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Macafee, D.A., Sagar, P.M., El-Khoury, T. and Hyland, R. (2012) Retrorectal Tumours: Optimization of Surgical Approach and Outcome. Colorectal Disease, 14, 1411-1417. http://dx.doi.org/10.1111/j.1463-1318.2012.02994.x</mixed-citation></ref><ref id="scirp.50723-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Uhlig, B.E. and Johnson, R.L. (1975) Presacral Tumors and Cysts in Adults. Diseases of the Colon Rectum, 18, 581-589. http://dx.doi.org/10.1007/BF02587141</mixed-citation></ref><ref id="scirp.50723-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Hjermstad, B.M. and Helwig, E.B. (1988) Tailgut Cysts. Report of 53 Cases. American Journal of Clinical Pathology, 89, 139-147.</mixed-citation></ref><ref id="scirp.50723-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Ludwig, K. and Kalady, M. (2005) Trans-Sacral Approaches for Presacral Cyst/Rectal Tumor. Operative Techniques in General Surgery, 7, 126-136. http://dx.doi.org/10.1053/j.optechgensurg.2005.08.005</mixed-citation></ref><ref id="scirp.50723-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Kye, B.H., Kim, H.J., Cho, H.M., Chin, H.M. and Kim, J.G. (2011) Clinicopathological Features of Retrorectal Tumors in Adults: 9 Years of Experience in a Single Institution. Journal of the Korean Surgical Society, 81, 122-127. 
http://dx.doi.org/10.4174/jkss.2011.81.2.122</mixed-citation></ref><ref id="scirp.50723-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Li, G.D., Chen, K., Fu, D., Ma, X.J., Sun, M.X., Sun, W., et al. (2011) Surgical Strategy for Presacral Tumors: Analysis of 33 Cases. Chinese Medical Journal (English Edition), 124, 4086-4091.</mixed-citation></ref><ref id="scirp.50723-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Bosca, A., Pous, S., Artes, M.J., Gomez, F., Castro, P.G. and Garcia-Granero, E. (2012) Tumours of the Retrorectal Space: Management and Outcome of a Heterogeneous Group of Diseases. Colorectal Disease, 14, 1418-1423. 
http://dx.doi.org/10.1111/j.1463-1318.2012.03016.x</mixed-citation></ref><ref id="scirp.50723-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Grahovac, G., Vilendecic, M., Vukelic-Markovic, M., Topic, I. and Lambasa, S. (2011) An Unexpected Obstacle: A Retrorectal Mass Went Undetected until the Patient Was in Labor. American Journal of Obstretics and Gynecology, 205, 578.</mixed-citation></ref><ref id="scirp.50723-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Foruhan, B. and Jennings, P.J. (1978) Unusual Presacral Tumours Obstructing Delivery. British Journal of Obstetrics and Gynaecology, 85, 231-233. http://dx.doi.org/10.1111/j.1471-0528.1978.tb10488.x</mixed-citation></ref><ref id="scirp.50723-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Oren, M., Lorber, B., Lee, S.H., Truex Jr., R.C. and Gennaro, A.R. (1977) Anterior Sacral Meningocele: Report of Five Cases and Review of the Literature. Diseases of the Colon Rectum, 20, 492-505.  
http://dx.doi.org/10.1007/BF02586588</mixed-citation></ref><ref id="scirp.50723-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Lee, S.C., Chun, Y.S., Jung, S.E., Park, K.W. and Kim, W.K. (1997) Currarino Triad: Anorectal Malformation, Sacral Bony Abnormality and Presacral Mass—A Review of 11 Cases. Journal of Pediatric Surgery, 32, 58-61. 
http://dx.doi.org/10.1016/S0022-3468(97)90094-4</mixed-citation></ref><ref id="scirp.50723-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Ludwig, K. and Kalady, M. (2005) Trans-Sacral Approaches for Presacral Cyst/Rectal Tumor. Operative Techniques in General Surgery, 7, 126-136. http://dx.doi.org/10.1053/j.optechgensurg.2005.08.005</mixed-citation></ref><ref id="scirp.50723-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Aranda-Narvaez, J.M., Gonzalez-Sanchez, A.J., Montiel-Casado, C., Sanchez-Perez, B., Jimenez-Mazure, C., Valle-Carbajo, M., et al. (2012) Posterior Approach (Kraske Procedure) for Surgical Treatment of Presacral Tumors. World Journal of Gastrointestinal Surgery, 4, 126-130. http://dx.doi.org/10.4240/wjgs.v4.i5.126</mixed-citation></ref><ref id="scirp.50723-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Demir, O.I., Obuz, F., Sagol, O. and Dicle, O. (2007) Contribution of Diffusion-Weighted MRI to the Differential Diagnosis of Hepatic Masses. Diagnostic and Interventional Radiology, 13, 81-86.</mixed-citation></ref><ref id="scirp.50723-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Avcu, S., Koseoglu, M.N., Ceylan, K., Bulut, M.D. and Unal, O. (2011) The Value of Diffusion-Weighted MRI in the Diagnosis of Malignant and Benign Urinary Bladder Lesions. The British Journal of Radiology, 84, 875-882. 
http://dx.doi.org/10.1259/bjr/30591350</mixed-citation></ref><ref id="scirp.50723-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Esen, M., Onur, M.R., Akpolat, N., Orhan, I. and Kocakoc, E. (2013) Utility of ADC Measurement on Diffusion-Weighted MRI in Differentiation of Prostate Cancer, Normal Prostate and Prostatitis. Quantitative Imaging in Medicine and Surgery, 3, 210-216.</mixed-citation></ref><ref id="scirp.50723-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Dahan, H., Arrive, L., Wendum, D., le Pointe, H.D., Djouhri, H. and Tubiana, J.M. (2001) Retrorectal Developmental Cysts in Adults: Clinical and Radiologic-Histopathologic Review, Differential Diagnosis and Treatment. Radiographics, 21, 575-584. http://dx.doi.org/10.1148/radiographics.21.3.g01ma13575</mixed-citation></ref><ref id="scirp.50723-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Pappalardo, G., Frattaroli, F.M., Casciani, E., Moles, N., Mascagni, D., Spoletini, D., et al. (2009) Retrorectal Tumors: The Choice of Surgical Approach Based on a New Classification. The American Surgeon, 75, 240-248.</mixed-citation></ref><ref id="scirp.50723-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Rifkin, M.D. and Marks, G.J. (1985) Transrectal US as an Adjunct in the Diagnosis of Rectal and Extrarectal Tumors. Radiology, 157, 499-502. http://dx.doi.org/10.1148/radiology.157.2.3901110</mixed-citation></ref><ref id="scirp.50723-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Gupta, S., Nguyen, H.L., Morello Jr., F.A., Ahrar, K., Wallace, M.J., Madoff, D.C., et al. (2004) Various Approaches for CT-Guided Percutaneous Biopsy of Deep Pelvic Lesions: Anatomic and Technical Considerations. Radiographics, 24, 175-189. http://dx.doi.org/10.1148/rg.241035063</mixed-citation></ref><ref id="scirp.50723-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Verazin, G., Rosen, L., Khubchandani, I.T., Sheets, J.A., Stasik, J.J. and Riether, R. (1986) Retrorectal Tumor: Is Biopsy Risky? Southern Medical Journal, 79, 1437-1439. http://dx.doi.org/10.1097/00007611-198611000-00028</mixed-citation></ref><ref id="scirp.50723-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Sell, M., Sampaolo, S., Di Lorio, G. and Theallier, A. (2004) Chordomas: A Histological and Immunohistochemical Study of Cases with and without Recurrent Tumors. Clinical Neuropathology, 23, 277-285.</mixed-citation></ref><ref id="scirp.50723-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Lorentziadis, M. and Poulantzas, I. (2010) Kraske’s Posterior Approach to the Mid Rectum: Does It Still Have a Place in the Surgeon’s Armentarium? Annals of Gastroenterology, 23, 302-306.</mixed-citation></ref><ref id="scirp.50723-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Localio, S.A., Eng, K. and Ranson, J.H. (1980) Abdominosacral Approach for Retrorectal Tumors. Annals of Surgery, 191, 555-560. http://dx.doi.org/10.1097/00000658-198005000-00006</mixed-citation></ref><ref id="scirp.50723-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Harvey, E.H., Young, M.R., Flanigan, T.L., Carlin, A.M., White, M.T., Tyburski, J.G., et al. (2004) Complications Are Increased with the Need for an Abdominal-Assisted Kraske Procedure. The American Surgeon, 70, 193-196.</mixed-citation></ref><ref id="scirp.50723-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Onaitis, M., Ludwig, K., Perez-Tamayo, A., Gottfried, M., Russell, L., Shadduck, P., et al. (2006) The Kraske Procedure: A Critical Analysis of a Surgical Approach for Mid-Rectal Lesions. Journal of Surgical Oncology, 94, 194-202. 
http://dx.doi.org/10.1002/jso.20591</mixed-citation></ref><ref id="scirp.50723-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, A., Hartley, J. and Monson, J.R. (2003) Local Excision of Rectal Tumors. Surgical Oncology, 12, 51-61. 
http://dx.doi.org/10.1016/S0960-7404(03)00007-0</mixed-citation></ref><ref id="scirp.50723-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Visser, B.C., Varma, M.G. and Welton, M.L. (2001) Local Therapy for Rectal Cancer. Surgical Oncology, 10, 61-69. 
http://dx.doi.org/10.1016/S0960-7404(01)00021-4</mixed-citation></ref><ref id="scirp.50723-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Wilson, S.E. and Gordon, H.E. (1969) Excision of Rectal Lesions by the Kraske Approach. The American Journal of Surgery, 118, 213-217. http://dx.doi.org/10.1016/0002-9610(69)90123-8</mixed-citation></ref></ref-list></back></article>